Literature DB >> 21912906

Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.

Wagner José Fávaro1, Amanda Cia Hetzl, Leonardo Oliveira Reis, Ubirajara Ferreira, Athanase Billis, Valéria Helena A Cagnon.   

Abstract

A space between neoplastic acini and prostatic stroma is not rare and studies have interpreted this as an artifact, considering the absence of endothelial cells indicating vascular invasion. Thus, the aims of this work were to characterize and correlate the occurrence and extent of retraction clefting with the reactivities of α and β dystroglycan (αDG, βDG), laminin, matrix metalloproteinase 2 (MMP-2), p63, insulin-like growth factor 1(IGF-1), vimentin, and fibroblast growth factor 2 (FGF-2). The study was based on nonneoplastic and neoplastic prostatic tissues obtained from necropsies and retropubic radical prostatectomies. The results showed that periacinar retraction clefting was significantly more frequent in prostatic carcinoma samples than in normal prostatic acini. Most of the neoplastic acini (72.0%) showed retraction clefting of more than 50% of circumference, which were significantly more frequent in Gleason score 7 and 6. Decreased collagen and reticular and elastic fibers were verified in the stroma around neoplastic acini. Weak and discontinuous αDG, βDG, and laminin immunoreactivities and intensified MMP-2, vimentin, IGF-1 and FGF-2 immunoreactivities were verified in the neoplastic acini; p63 immunoreactivity was negative in all carcinomas. Thus, these findings showed that the lack of epithelial basal cells, DGs, and laminin and increased MMP-2, IGF-1, and FGF-7 could be considered important pathways in periacinar retraction occurrence. This study demonstrated the origin of and the biological mechanisms responsible for periacinar retraction clefting in prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912906     DOI: 10.1007/s12253-011-9440-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex.

Authors:  H Yamada; F Saito; H Fukuta-Ohi; D Zhong; A Hase; K Arai; A Okuyama; R Maekawa; T Shimizu; K Matsumura
Journal:  Hum Mol Genet       Date:  2001-07-15       Impact factor: 6.150

2.  An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release.

Authors:  A Aigner; M Butscheid; P Kunkel; E Krause; K Lamszus; A Wellstein; F Czubayko
Journal:  Int J Cancer       Date:  2001-05-15       Impact factor: 7.396

3.  Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Aida Cviko; Hrvoje Cupic; Ljubica Odak; Mladen Belicza
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

Review 4.  The other side of MMPs: protective roles in tumor progression.

Authors:  Michelle D Martin; Lynn M Matrisian
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

5.  Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma.

Authors:  D Tomas; M Ulamec; T Hudolin; S Bulimbasić; M Belicza; B Kruslin
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-05-02       Impact factor: 5.554

6.  The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.

Authors:  Davor Tomas; Bozo Kruslin
Journal:  Prostate       Date:  2004-12-01       Impact factor: 4.104

7.  Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact?

Authors:  Bozo Kruslin; Davor Tomas; Hermann Rogatsch; Irena Novosel; Hrvoje Cupić; Mladen Belicza; Ognjen Kraus; Gregor Mikuz
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

Review 8.  Matrix metalloproteinases in tumor-host cell communication.

Authors:  Conor C Lynch; Lynn M Matrisian
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

Review 9.  Novel targeting of apoptosis pathways for prostate cancer therapy.

Authors:  Jason B Garrison; Natasha Kyprianou
Journal:  Curr Cancer Drug Targets       Date:  2004-02       Impact factor: 3.428

10.  Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

Authors:  J I Epstein
Journal:  Hum Pathol       Date:  1995-02       Impact factor: 3.466

View more
  5 in total

1.  High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.

Authors:  Tihana Džombeta; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2017-07-27       Impact factor: 3.201

2.  Steroid Hormone Receptors as Potential Mediators of the Clinical Effects of Dutasteride: A Prospective, Randomized, Double-Blind Study.

Authors:  João C C Alonso; Leonardo O Reis; Patrick V Garcia; Ubirajara Ferreira; Wagner E Matheus; Fabiano A Simões; Ronald F Rejowski; Maria Isabel C Alonso-Vale; Wagner J Fávaro
Journal:  Am J Mens Health       Date:  2016-07-08

Review 3.  Prostate cancer stroma: an important factor in cancer growth and progression.

Authors:  Božo Krušlin; Monika Ulamec; Davor Tomas
Journal:  Bosn J Basic Med Sci       Date:  2015-05-13       Impact factor: 3.363

Review 4.  The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.

Authors:  Marley J Binder; Alister C Ward
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

5.  The Prognostic Value of Retraction Clefts in Chinese Invasive Breast Cancer Patients.

Authors:  Liangliang Huang; Yujie Li; Jun Du; Heng Li; Mengmeng Lu; Yuting Wang; Wenchao Zhou; Wei Wang; Haibo Wu
Journal:  Pathol Oncol Res       Date:  2021-04-21       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.